Huadong Medicine Co., Ltd
Huadong Medicine Co., Ltd., a prominent player in the pharmaceutical preparation manufacturing industry, is headquartered in China (CN). Established in 1996, the company has made significant strides in developing high-quality pharmaceutical products, focusing on both generic and innovative medications.
With a strong operational presence across various regions in China, Huadong Medicine is renowned for its commitment to research and development, producing a diverse range of core products that include injectables, tablets, and capsules. Their unique formulations and adherence to stringent quality standards set them apart in a competitive market.
Recognised for their contributions to healthcare, Huadong Medicine has achieved notable milestones, solidifying its position as a trusted name in the pharmaceutical sector. The company continues to expand its influence, driven by a dedication to improving patient outcomes and advancing medical science.
-14 vs industry average
Huadong Medicine Co., Ltd’s score of 24 is lower than 36% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Huadong Medicine Co., Ltd?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Pharmaceutical Preparation Manufacturing has below-average carbon intensity
Industry performance
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Emissions trajectory 2020 – 2027
Reported emissions
Scope 3 accounts for ••• of total emissions.
Huadong Medicine Co., Ltd's reported carbon emissions
Huadong Medicine Co., Ltd., a pharmaceutical preparation manufacturer based in China (CN), reported approximately 186.95 million kg CO2e for Scope 1 and Scope 2 emissions in 2024. This figure represents an increase from approximately 152.10 million kg CO2e in 2023 and approximately 108.60 million kg CO2e in 2022.
For 2024, Scope 1 emissions were approximately 15.59 million kg CO2e, and Scope 2 emissions were approximately 171.36 million kg CO2e. In 2023, Scope 1 emissions were approximately 14.29 million kg CO2e, with Scope 2 emissions at approximately 137.81 million kg CO2e. The company has not yet disclosed Scope 3 emissions data.
Huadong Medicine Co., Ltd. has not publicly stated specific carbon reduction targets or joined climate initiatives such as the Science Based Targets initiative (SBTi) or the Climate Pledge, according to the latest available information. Its climate commitments and emission reduction strategies are not detailed in the provided data.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Huadong Medicine Co., Ltd’s Climate Goals (2030 & 2050)
No climate goals have been disclosed for Huadong Medicine Co., Ltd yet.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Emissions comparison with industry peers
View similar organisationsUsage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project